Frontlight ResearchEarly access
WithdrawnNo phase
Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT
Key facts
- Who runs it
- Case Comprehensive Cancer Center
- Where
- Cleveland, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 1 Apr 2024
- Ended
- 30 Jun 2025
- Type of study
- Interventional
- Treatments tested
- Mycobiome Supporting Diet
- Record updated
- 26 April 2024
- Why it stopped
- Administrative decision
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Eligible for first autologous transplant for myeloma
- Willing to adhere to the allowed and disallowed foods of the diet plan
- Able to get and prepare their own food items for all meals during the study
Who cannot take part
- Prior bowel resection
- Patients who received antifungal therapy in 3 days prior to enrollment
- Patients who received steroid therapy in 7 days prior to enrollment
- Active inflammatory bowel disease, celiac disease, other chronic intestinal disorders
- Inability to tolerate the study diet due to allergies/ intolerance/ preference
- Any condition that the investigator feels may limit the volunteer's ability to complete the study protocol
- Patients with absolute neutrophil count (ANC) < 1000 on long term antibacterial prophylaxis ongoing 3 days prior to enrollment
- Pregnant women, planning to get pregnant or breastfeeding
- Inability to consent to trial
- Patients with restrictions in diet including inability to have oral nutrition with regular consistency
Where in United States
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer CenterCleveland, United States
About the trial
What the trial wants to find out
The purpose of this study is to determine if this specific Mycobiome Supporting Diet (MSD diet) can help reduce gut inflammation during post-transplant period. The MSD is an special diet which will be explained in detail by a dietician that works by supporting the body's good gut bacteria and fungi.
The group in the trial
- Mycobiome Supporting DietTreatment being tested
Participants will be able to abide by the allowed and disallowed foods in MSD diet for at least four consecutive weeks prior to conditioning and up to 10 days after transplant. Participants will maintain a diary of foods they consume and any adverse effects they are experiencing and will self- collect fecal samples 28 days before transplant, 2 days before transplant and 10 days after transplant
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Mycobiome Supporting Diet (MSD) to Reduce Gastrointestinal (GI) Toxicity Associated With Autologous Stem Cell Transplant (ASCT) For Patients With Multiple Myeloma (MM)
- Record updated
- 26 April 2024